HOUSTON, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Systemic Bio™, a 3D Systems company (NYSE: DDD), is honored to announce its selection as a Top 10 Finalist for the prestigious SLAS 2025 Innovation Award.

Neither Systemic Bio nor 3D Systems undertakes any obligation to update or revise any forward-looking statements made by management or on its behalf, whether as a result of future developments, ...

HOUSTON, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Systemic Bio™, a 3D Systems (NYSE:DDD) company, is excited to announce the acceptance of two abstracts for presentation at the prestigious Society of ...

Systemic Bio™, a subsidiary of 3D Systems, has won the SLAS 2025 Innovation Award for its h-VIOS™ platform, which enhances drug discovery by using bioprinted human tissues to evaluate antibody-drug ...

15,000 sq. ft. facility in TMC Innovation Factory Labs will house Systemic Bio’s R&D, production of patent-pending h-VIOS ™ organ-on-a-chip platform Cleanroom manufacturing intended to support sterile ...